1187236-18-5

Basic information

• Product Name: IMidazo[1,2-a]pyridine-2-carboxylic acid, 7-broMo-, ethyl ester
• Synonyms: IMidazo[1,2-a]pyridine-2-carboxylic acid, 7-broMo-, ethyl ester;7-BroMo-iMidazo[1,2-a]pyridine-2-carboxylic acid ethyl ester;ethyl 7-bromoH-imidazo[1,2-a]pyridine-2-carboxylate
• CAS NO: 1187236-18-5
• Molecular Formula: C₁₀H₉BrN₂O₂
• Molecular Weight: 269.09466
• Mol File: 1187236-18-5.mol
• Article Data: 6

Chemical Properties

• Melting Point: 188-190℃
• Appearance: /
• Density: 1.60±0.1 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• PKA: 1.63±0.50(Predicted)
• CAS DataBase Reference: IMidazo[1,2-a]pyridine-2-carboxylic acid, 7-broMo-, ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: IMidazo[1,2-a]pyridine-2-carboxylic acid, 7-broMo-, ethyl ester(1187236-18-5)
• EPA Substance Registry System: IMidazo[1,2-a]pyridine-2-carboxylic acid, 7-broMo-, ethyl ester(1187236-18-5)

Safety Data

• Hazardous Substances Data: 1187236-18-5(Hazardous Substances Data)

Usage

General Description

Imidazo[1,2-a]pyridine-2-carboxylic acid, 7-bromo-, ethyl ester is a chemical compound with the molecular formula C11H9BrN2O2. It is commonly used in the pharmaceutical industry as an intermediate for the synthesis of various biologically active compounds. This chemical is also known for its potential as an anti-cancer and anti-inflammatory agent. It is typically synthesized through esterification of imidazo[1,2-a]pyridine-2-carboxylic acid with ethanol in the presence of a suitable catalyst. Imidazo[1,2-a]pyridine-2-carboxylic acid, 7-bromo-, ethyl ester is considered to be a valuable and versatile building block for the development of new drugs and therapeutic agents.

Upstream product

• 84249-14-9 2-amino-4-bromopyridine 
• 70-23-5 ethyl Bromopyruvate 

Downstream Products

• 1187236-21-0 (7-bromoimidazo[1,2-a]pyridin-2-yl)methanol 
• 1202179-45-0 7-bromo-2-(difluoromethyl)imidazo[1,2-a]pyridine 
• 1541189-95-0 C₁₇H₁₂N₄O₃ 
• 1541189-94-9 C₁₉H₁₆N₄O₃ 
• 1541187-87-4 morpholin-4-yl-{7-[4-(2H-pyrazol-3-yl)phenoxy]imidazo[1,2-a]pyridin-2-yl}methanone 
• 1541189-93-8 C₂₅H₃₀N₄O₄Si 
• 1454904-55-2 2,2-difluoro-N-((1S,2R)-1-fluoromethyl-2-hydroxy-2-{4-[2-(methanesulfonylaminomethyl)imidazo[1,2-a]pyridin-7-yl]phenyl}ethyl)acetamide 
• 1454907-27-7 N-{7-[4-((1R,2S)-2-amino-3-fluoro-1-hydroxypropyl)phenyl]imidazo[1,2-a]pyridin-2-ylmethyl}methanesulfonamide 
• 1454907-26-6 (4S,5R)-4-fluoromethyl-5-{4-[2-(methanesulfonylaminomethyl)imidazo[1,2-a]pyridin-7-yl]phenyl}-2,2-dimethyloxazolidine-3-carboxylic acid tert-butyl ester 
• 1019023-07-4 7-bromo-2-chloromethylimidazo[1,2-a]pyridine 

Relevant articles and documents

TLR2 MODULATOR COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF

The present disclosure relates to compounds which modulate the activity of Toll-like receptor (TLR) proteins, including agonists or activators, partial agonists, and antagonists. Of particular interest of compounds that modulate the activity of TLR2, as well as methods of using such compounds to treat cancer and other disorders associated with a TLR2 pathway.

Substituted heteroaryl compounds and compositions and uses thereof (by machine translation)

The invention discloses substituted heteroaryl compounds and compositions thereof and their use. The compounds of formula (I) compound or type shown in (I) a compound represented by stereo isomers, tautomers, nitrogen oxide, solvate, metabolite, pharmaceutically acceptable salt or its prodrug. The invention also provides a pharmaceutical composition, the compounds and pharmaceutical compositions can be regulated protein kinase, particularly Aurora kinase and JAK kinase activity, for the prevention, treatment, treatment and reduce protein kinase, in particular JAK kinase activity mediated diseases or disorders. (by machine translation)

PHENICOL ANTIBACTERIALS

The present invention provides novel phenicol derivatives, their use for the treatment of infections in mammals, pharmaceutical composition containing these novel compounds, and methods for the preparation of these compounds.